Khiron Life SciencesKHRNF
13F holders, Q2 2024 (June 30)1holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Khiron Life Sciences Corp. (KHRNF) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holder was FNY Investment Advisers, LLC ($0).
- Company
- Khiron Life Sciences Corp.
- CUSIP
- 49374L306
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 1,000 shares bought, net +1,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| FNY Investment Advisers, LLC | 0.00% | Add +100.0% | 2,000 | $0 |
"% of holder's portfolio" is KHRNF's weight in each manager's 13F, not the share of Khiron Life Sciences Corp. the manager owns.